The prospect of Biopharmaceutics is broad, and the overseas distribution of China still needs to be strengthened

[China Pharmaceutical network industry trends] recently, the literature and information center of the Chinese Academy of Sciences and the American Chemical Abstracts Agency jointly released the research and development situation analysis report on biopharmaceuticals and the research and development situation analysis report on antibody drugs in Shanghai The report shows that developed countries such as the United States, Japan, the United Kingdom and Germany dominate in this field According to the report, China and other developing countries have increased their investment and support in the field of biopharmaceuticals in recent years, but their overseas layout still needs to be strengthened It is also mentioned that scientific research institutions and universities are still the main force of basic research, while the application is dominated by enterprises, suggesting that the alliance and transformation of industry university research need to be strengthened In addition, the report also pointed out that with more and more new targets being found, in the future, more and more preparation technologies will be used to realize the recombination and improvement of a variety of antibodies, so as to improve the production efficiency, quality and application of antibody products to a higher level, and open up a new and broader prospect for the research and development and clinical application of biopharmaceuticals According to the above content, the future of biopharmaceutical has a broad prospect In addition to increasing the continuous investment in this field, China also needs to strengthen the improvement of overseas, talent team, production, learning and research, preparation technology and other aspects According to overseas statistics, in the field of biopharmaceutical, the top five countries of paper output are the United States, China, Japan, the United Kingdom and Germany, and the total amount of papers in the five countries accounts for 64% of the total amount of papers in the world The top five applicants are the United States, China, Japan, Germany and South Korea, accounting for more than 67% of the global total Therefore, on the overseas side, China should make great efforts to build domestic products It is understood that with the continuous launch of new drug policies, a number of key technologies and production processes of drug creation have been broken through in China, and even a number of innovative drugs independently developed in China have appeared on the stage, which shows that China has broken the monopoly of foreign drugs in some pharmaceutical fields, and also gives Chinese people hope for the results of domestic drug applications overseas Talent team biopharmaceutical has the characteristics of strong technology dependence, high knowledge density, strong specificity and small side effects Among them, the requirements for technology, knowledge and specialty are very high, which also requires the introduction of more talents and teams in this field Domestic biomedical enterprises, such as through the mode of production, teaching and research, actively cultivate talents in Colleges and universities, and bring more vitality to enterprises In addition, with the strong support for the biomedical industry and the continuous policy spring breeze in China, more and more returned elites are coming back to China, which is also very beneficial for the biomedical industry in China According to statistics, in developed countries, the relationship between biomedicine and medical devices is 1:1, but in China, the current proportion is only 7:1, the proportion of biomedical devices is not high, there is still a lot of room for development At the round table, industry insiders pointed out that although the market scale of biomedical device industry in China is not large enough, it has grown rapidly in recent years Therefore, there is still a lot of room for progress for the domestic biomedical device industry We should strive to create more preparation technology and medical equipment, break the dependence on imported equipment, and help the domestic biomedical industry develop better.